Serum phosphorus reduction in dialysis patients treated with cinacalcet for secondary hyperparathyroidism results mainly from parathyroid hormone reduction

BACKGROUND: The calcimimetic cinacalcet lowers parathyroid hormone (PTH), calcium (Ca) and phosphorus (P) in dialysis patients with secondary hyperparathyroidism (SHPT). We explored serum P changes in dialysis patients treated with cinacalcet, while controlling for vitamin D sterol and phosphate bin...

Descripción completa

Detalles Bibliográficos
Autores principales: Zitt, Emanuel, Fouque, Denis, Jacobson, Stefan H., Malberti, Fabio, Ryba, Miroslav, Ureña, Pablo, Rix, Marianne, Dehmel, Bastian, Manamley, Nick, Vervloet, Marc
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Oxford University Press 2013
Materias:
Original Contributions
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3665312/
https://www.ncbi.nlm.nih.gov/pubmed/23717787
http://dx.doi.org/10.1093/ckj/sft026

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3665312/
https://www.ncbi.nlm.nih.gov/pubmed/23717787
http://dx.doi.org/10.1093/ckj/sft026

Ejemplares similares